Lupin Outlook for the Week (Aug 21, 2017 – Aug 25, 2017)
EquityPandit’s Outlook for Lupin for the week (Aug 21, 2017 – Aug 25, 2017) : LUPIN: Lupin closed the week on absolutely flat...
Tag : Lupin
Lupin Outlook for the Week (Aug 14, 2017 – Aug 18, 2017)
EquityPandit’s Outlook for Lupin for the week (Aug 14, 2017 – Aug 18, 2017) : LUPIN: Lupin closed the week on negative note...
Lupin has received USFDA approval for cholesterol drug
Lupin has got the US health regulator’s approval for marketing Pitavastatin tablets which is used in lowering cholesterol. Lupin has said in a BSE filing...
Lupin Outlook for the Week (Aug 07, 2017 – Aug 11, 2017)
EquityPandit’s Outlook for Lupin for the week (Aug 07, 2017 – Aug 11, 2017) : LUPIN: Lupin closed the week on negative note...
USFDA completes PAI of Lupin’s Aurangabad plant
The US health regulator has concluded the prior approval inspection (PAI) of Lupin’s Aurangabad manufacturing plant. Lupin has said in a statement that during the...
Lupin Outlook for the Week (July 31, 2017 – Aug 04, 2017)
EquityPandit’s Outlook for Lupin for the week (July 31, 2017 – Aug 04, 2017) : LUPIN: Lupin closed the week on negative note losing...
Lupin Outlook for the Week (July 24, 2017 – July 28, 2017)
EquityPandit’s Outlook for Lupin for the week (July 24, 2017 – July 28, 2017) : LUPIN: Lupin closed the week on positive note...
Lupin Outlook for the Week (July 17, 2017 – July 21, 2017)
EquityPandit’s Outlook for Lupin for the week (July 17, 2017 – July 21, 2017) : LUPIN: Lupin closed the week on positive note...
Lupin receives USFDA approval to market anti-fungal capsules
Lupin has got the approval from the US health regulator for marketing its Flucytosine capsules that are used in treating fungal infections. Lupin has said...
Lupin Outlook for the Week (July 10, 2017 – July 14, 2017)
EquityPandit’s Outlook for Lupin for the week (July 10, 2017 – July 14, 2017) : LUPIN: Lupin closed the week on positive note...